Efficacy and safety of a new salicylic acid derivative as a complement of vitamin A acid in acne treatment.
La Roche-Posay Pharmaceutical Laboratories, Asnières, France.
A
A
Rougier
A
A
Richard
D000152:Acne Vulgaris / Q000188:drug therapy*; D000293:Adolescent; D000328:Adult; D004338:Drug Combinations; D005260:Female; D006801:Humans; D007641:Keratolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D009824:Ointments; D020156:Salicylic Acid / Q000008:administration & dosage / Q000627:therapeutic use*; D016896:Treatment Outcome; D014801:Vitamin A / Q000008:administration & dosage / Q000627:therapeutic use*
D004338:Drug Combinations; D007641:Keratolytic Agents; D009824:Ointments; D014801:Vitamin A; D020156:Salicylic Acid